N/A(healthy adults)
Conditions
Interventions
Using of test product (2 times in a day
4 weeks) and ingesting of test product (2 tablets in a day
4 weeks).
Sponsors
TES Holdings Co., Ltd.
DRC Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: [1]Healthy Japanese females aged 20-50 years. [2]Individuals whose BMI is less than 30. [3]Individuals who worry about thigh girth. [4]Individuals who do not have exercise habits. [5]Individuals whose written informed consent has been obtained. [6]Individuals who can consent a 3D imaging with a paper brassiere and pants. [7]Individuals judged appropriate for the study by the principal.
Exclusion criteria
Exclusion criteria: [1]Individuals using medical products. [2]Individuals who are patient or have a history of psychiatric disease, high blood pressure, diabetes, and hyperlipidemia. [3]Individuals who used or applied a drug for treatment of disease in the past 1 month. [4]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. [5]Individuals with skin disease, such as atopic dermatitis. [6]Individuals who have sensitive skin. [7]Individuals who are sensitive to a test producer other foods, and medical products. [8]Individuals who are based on average alcohol per 1 day and exceeds 60g/day. [9]Individuals whose life style will change during the test period (ex. travel for a long time). [10]Individuals who had a habit to use and ingest health-promoting foods, foods for specified health uses, health foods, or supplements which call for slimming effects in the past 3 months or will use or ingest those foods during the test period. [11]Individuals who have a history to be treated with an operation to improve skin condition in the past 3 months. [12]Individuals who are or are possibly pregnant, or are lactating. [13]Individuals who participated in other clinical studies in the past 3 months. [14]Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| [1]Indexes on sliming (waist girth, hip girth, thigh girth, calf girth, upper arm girth, thigh girth and volume with 3D imaging) (Week 0, Week 4). | — |
Secondary
| Measure | Time frame |
|---|---|
| *Secondary indexes [1]Weight, body fat percentage, BMI (Week 0, Week 4) [2]Capillary vessel measurement (Week 0, Week 4) *Safety [1]Blood pressure, pulsation (Week 0, Week 4) [2]Subject's diary (From the first day of ingestion of a test material to the last day of the test) [3]Doctor's questions (Week 0, Week 4) | — |
Countries
Japan
Contacts
Public ContactRyoma Shimizu
TES Holdings Co., Ltd. Administrative Department of Clinical Trials
Outcome results
None listed